2m 2m 2m 2m 2m 2m 2m
SERA PROGNSTCS-A (SERA)
NASDAQ
$2.12+$0.02 (+0.71%)
Price as of Aug 03, 2026 4:10 PM EDT- $77.9MMarket Cap
- -18.92%1-Year Change
- Medical DevicesIndustry
SERA PROGNSTCS-A (SERA)
$2.12+$0.02 (+0.71%)
SERA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.10 | ||
Change | +$0.06 (+2.94%) | ||
Open | $1.98 | ||
High | $2.19 | ||
Low | $1.98 | ||
Previous Close | $2.04 | ||
Volume | 15,272 | ||
30-Day Average Volume | 36,079 | ||
1-Week Change | 2.44% | ||
1-Month Change | 5.00% | ||
1-Year Change | -18.92% | ||
3-Year Change | -28.81% | ||
5-Year Change | -82.10% | ||
Fundamentals | |||
Shares Outstanding | 38.2M | ||
Total Assets | $93.5M | ||
Market Cap | $77.9M | ||
Enterprise Value | $73.7M | ||
Period: QTR TTM FY | |||
Revenue | $14,000.00 | ||
Net Income | -$8.4M | ||
Free Cash Flow | -$8.8M | ||
EBIT | -$8.4M | ||
EBITDA | -$8.2M | ||
Net Working Capital | $26.3M | ||
EPS | -$0.17 | ||
Enterprise Value/EBITDA | -9 | ||
Enterprise Value/Revenue | 5,267 | ||
P/B | 1 | ||
P/E | -12 | ||
PEG | 2 | ||
Price/Free Cash Flow | -9 | ||
Price/Operating Cash Flow | -9 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue